Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00162331 · ClinicalTrials.gov registry record · Phase 4
CARDIOLITE-413: A Study for Patients Who Had a PCI for an Acute MI
A Phase 4 study, sponsored by Lantheus Medical Imaging.
- Completed
- Registry status
- Phase 4
- Development phase
- 74
- Enrollment target
NCT00162331 is a Phase 4 study that has completed, run by Lantheus Medical Imaging. The registered enrollment target is 74 participants.
The verdict
NCT00162331, a Phase 4 study, has completed, sponsored by Lantheus Medical Imaging.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 74 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to learn if there are any changes in how blood gets to your heart muscle and if your heart size changed after your heart attack.
Interventions
- DRUG Technetium Tc99m Sestamibi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2005-01 |
| Est. Completion | 2007-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00162331
The ClinicalTrials.gov registry entry for NCT00162331 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lantheus Medical Imaging, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Technetium Tc99m Sestamibi is the first listed.
NCT00162331 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00162331 about?
NCT00162331 is a clinical study titled "CARDIOLITE-413: A Study for Patients Who Had a PCI for an Acute MI". The purpose of this clinical study is to learn if there are any changes in how blood gets to your heart muscle and if your heart size changed after your heart attack.
What is the current status of trial NCT00162331?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 74 participants. The study started on 2005-01. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00162331?
The interventions under investigation include: Technetium Tc99m Sestamibi (DRUG).
Who is sponsoring clinical trial NCT00162331?
This trial is sponsored by Lantheus Medical Imaging, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.